Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice
Maria del Carmen Parquet, Kimberley A. Savage, David Allan, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 9
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
Aref Shariati, Maniya Arshadi, Mohammad Ali Khosrojerdi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 147
The role of bacterial metabolism in antimicrobial resistance
Mehrose Ahmad, Sai Varun Aduru, Robert P. Smith, et al.
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 4
Host Innate Immune Responses to Acinetobacter baumannii Infection
Wangxue Chen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 64
A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
Brian Luna, Vincent Trebosc, Bosul Lee, et al.
Nature Microbiology (2020) Vol. 5, Iss. 9, pp. 1134-1143
Open Access | Times Cited: 59
Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections
Víctor Vinuesa, Michael J. McConnell
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2876-2876
Open Access | Times Cited: 50
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?
Giovanni Stelitano, Mario Cocorullo, Matteo Mori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6181-6181
Open Access | Times Cited: 14
Iron Chelation in Local Infection
Cassidy Scott, Gaurav Arora, Kayle Dickson, et al.
Molecules (2021) Vol. 26, Iss. 1, pp. 189-189
Open Access | Times Cited: 30
Methicillin-resistant Staphylococcus pseudintermedius: epidemiological changes, antibiotic resistance, and alternative therapeutic strategies
Francesca Paola Nocera, Luisa De Martino
Veterinary Research Communications (2024) Vol. 48, Iss. 6, pp. 3505-3515
Open Access | Times Cited: 4
Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles’ heel of antibiotic-resistant microbes
Bruce E. Holbein, M. Trisha C. Ang, David Allan, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 4, pp. 2789-2808
Open Access | Times Cited: 18
Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis
Christine Lehmann, Maral Aali, Juan Zhou, et al.
Life (2021) Vol. 11, Iss. 1, pp. 57-57
Open Access | Times Cited: 17
Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection
Greg Harris, Bruce E. Holbein, Hongyan Zhou, et al.
Infection and Immunity (2019) Vol. 87, Iss. 11
Open Access | Times Cited: 18
Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
David Allan, Bruce E. Holbein
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1642-1642
Open Access | Times Cited: 8
Iron Sequestrant DIBI, a Potential Alternative for Nares Decolonization of Methicillin-Resistant Staphylococcus aureus, Is Anti-infective and Inhibitory for Mupirocin-Resistant Isolates
David Allan, Maria del Carmen Parquet, Kimberley A. Savage, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 3
Open Access | Times Cited: 11
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains
Francesca Paola Nocera, Giuseppe Iovane, Luisa De Martino, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 656-656
Open Access | Times Cited: 7
Iron in infectious diseases friend or foe?: The role of gut microbiota
Zinnet Şevval Aksoyalp, Aybala Temel, Betül Rabia Erdoğan
Journal of Trace Elements in Medicine and Biology (2022) Vol. 75, pp. 127093-127093
Closed Access | Times Cited: 7
Comparative genomic and phenotypic analysis of low- and high-virulent Acinetobacter baumannii strains: insights into antimicrobial resistance and virulence potential
Man-Hwan Oh, Nayeong Kim, Md Minarul Islam, et al.
Microbial Pathogenesis (2024) Vol. 198, pp. 107118-107118
Open Access | Times Cited: 1
Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity
Roger Gumbau‐Brisa, M. Trisha C. Ang, Bruce E. Holbein, et al.
BioMetals (2020) Vol. 33, Iss. 6, pp. 339-351
Closed Access | Times Cited: 10
DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage
Anna L. Greenshields, Melanie R. Power Coombs, Wasundara Fernando, et al.
BioMetals (2019) Vol. 32, Iss. 6, pp. 909-921
Closed Access | Times Cited: 9
The intracellular phase of extracellular respiratory tract bacterial pathogens and its role on pathogen-host interactions during infection
Yanina Lamberti, Kristin Surmann
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 3, pp. 197-205
Closed Access | Times Cited: 8
The novel iron chelator, DIBI, attenuates inflammation and improves outcome in colon ascendens stent peritonitis-induced experimental sepsis
Danielle Fokam, Maral Aali, Kayle Dickson, et al.
Clinical Hemorheology and Microcirculation (2020) Vol. 76, Iss. 2, pp. 241-261
Closed Access | Times Cited: 7
Structure prediction and discovery of inhibitors against phosphopantothenoyl cysteine synthetase of Acinetobacter baumannii
Akshita Gupta, V. Viswanathan, Pradeep Pant, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 21, pp. 11405-11417
Closed Access | Times Cited: 6
Host–Pathogen Interactions in Acinetobacter Baumannii Infection: Recent Advances and Future Challenges
Wangxue Chen
Future Microbiology (2020) Vol. 15, Iss. 10, pp. 841-845
Closed Access | Times Cited: 5
Exploiting the Achilles’ Heel of Iron Dependence in Antibiotic Resistant Bacteria with New Antimicrobial Iron Withdrawal Agents
Bruce E. Holbein, M. Trisha C. Ang, David Allan, et al.
Sustainable agriculture reviews (2021), pp. 251-311
Closed Access | Times Cited: 4
Anti-inflammatory iron chelator, DIBI, reduces leukocyte-endothelial adhesion and clinical symptoms of LPS-induced interstitial cystitis in mice
Georg Hagn, Bruce E. Holbein, Juan Zhou, et al.
Clinical Hemorheology and Microcirculation (2021) Vol. 79, Iss. 3, pp. 395-406
Closed Access | Times Cited: 4
Potential additional effects of iron chelators on antimicrobial- impregnated central venous catheters
Kazuhiro Itoh, Hiroshi Tsutani, Yasuhiko Mitsuke, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top